Glucose Phosphorylation is Required for Insulin-dependent MTOR Signalling in the Heart

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2007 Jun 8

PMID 17553476

Citations 47

Authors

Saumya Sharma

Patrick H Guthrie

Suzanne S Chan

Syed Haq

Heinrich Taegtmeyer

Affiliations

Soon will be listed here.

Abstract

Objective: Insulin regulates both glucose uptake and postnatal cardiac growth. The anabolic effects of insulin are mediated by the mammalian target of rapamycin (mTOR), an evolutionarily conserved kinase which is also a convergence point between nutrient sensing and cell growth. We postulated that mTOR signalling in the heart requires the metabolism of glucose.

Methods: We interrogated the insulin-mediated mTOR signalling pathway in response to different metabolic interventions regulating substrate metabolism in the isolated working rat heart and in isolated cardiomyocytes.

Results: Although insulin enhanced Akt activity, phosphorylation of mTOR and its downstream targets (p70S6K and 4EBP1) required the addition of glucose. Glucose-dependent p70S6K phosphorylation was independent of the hexosamine biosynthetic pathway, the AMP kinase pathway, and the pentose phosphate pathway. However, inhibition of glycolysis downstream of hexokinase markedly enhanced p70S6K phosphorylation. Furthermore, 2-deoxyglucose activated p70S6K suggesting that phosphorylation of glucose is required for carbohydrate-mediated mTOR signalling in the heart. Lastly, we also found enhanced p70S6K phosphorylation in the hearts of diabetic rats.

Conclusion: Phosphorylation of glucose is necessary for insulin-dependent mTOR activity in the heart, suggesting a link between intermediary metabolism and cardiac growth.

Citing Articles

Resveratrol as a cardioprotective adjuvant for 5-fluorouracil in the treatment of gastric cancer cells.

Liu L, Wang Y, Dong Y, Lin S, Guan W, Song J Braz J Med Biol Res. 2024; 57:e13537.

PMID: 39258669 PMC: 11379349. DOI: 10.1590/1414-431X2024e13537.

Metabolite signaling in the heart.

Flam E, Arany Z Nat Cardiovasc Res. 2024; 2(6):504-516.

PMID: 39195876 DOI: 10.1038/s44161-023-00270-6.

Insulin-Heart Axis: Bridging Physiology to Insulin Resistance.

Caturano A, Galiero R, Vetrano E, Sardu C, Rinaldi L, Russo V Int J Mol Sci. 2024; 25(15).

PMID: 39125938 PMC: 11313400. DOI: 10.3390/ijms25158369.

Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development.

Caturano A, Vetrano E, Galiero R, Salvatore T, Docimo G, Epifani R Rev Cardiovasc Med. 2024; 23(5):165.

PMID: 39077592 PMC: 11273913. DOI: 10.31083/j.rcm2305165.

Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment.

Huang X, Hu L, Long Z, Wang X, Wu J, Cai J Rev Cardiovasc Med. 2024; 25(3):93.

PMID: 39076964 PMC: 11263885. DOI: 10.31083/j.rcm2503093.

References

Shioi T, McMullen J, Kang P, Douglas P, Obata T, Franke T . Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol. 2002; 22(8):2799-809. PMC: 133704. DOI: 10.1128/MCB.22.8.2799-2809.2002. View

Belke D, Betuing S, Tuttle M, Graveleau C, Young M, Pham M . Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest. 2002; 109(5):629-39. PMC: 150890. DOI: 10.1172/JCI13946. View

Sakamoto K, Goodyear L . Invited review: intracellular signaling in contracting skeletal muscle. J Appl Physiol (1985). 2002; 93(1):369-83. DOI: 10.1152/japplphysiol.00167.2002. View

Proud C . Regulation of mammalian translation factors by nutrients. Eur J Biochem. 2002; 269(22):5338-49. DOI: 10.1046/j.1432-1033.2002.03292.x. View

Crespo J, Hall M . Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 2002; 66(4):579-91, table of contents. PMC: 134654. DOI: 10.1128/MMBR.66.4.579-591.2002. View

Shioi T, McMullen J, Tarnavski O, Converso K, Sherwood M, Manning W . Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation. 2003; 107(12):1664-70. DOI: 10.1161/01.CIR.0000057979.36322.88. View

Barbieri M, Bonafe M, Franceschi C, Paolisso G . Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab. 2003; 285(5):E1064-71. DOI: 10.1152/ajpendo.00296.2003. View

Proud C . Role of mTOR signalling in the control of translation initiation and elongation by nutrients. Curr Top Microbiol Immunol. 2003; 279:215-44. DOI: 10.1007/978-3-642-18930-2_13. View

Razeghi P, Sharma S, Ying J, Li Y, Stepkowski S, Reid M . Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation. 2003; 108(20):2536-41. DOI: 10.1161/01.CIR.0000096481.45105.13. View

10.

Nikolaidis L, Sturzu A, Stolarski C, Elahi D, Shen Y, Shannon R . The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res. 2004; 61(2):297-306. DOI: 10.1016/j.cardiores.2003.11.027. View

11.

Cheng S, Fryer L, Carling D, Shepherd P . Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem. 2004; 279(16):15719-22. DOI: 10.1074/jbc.C300534200. View

12.

Lei B, Lionetti V, Young M, Chandler M, DAgostino C, Kang E . Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol. 2004; 36(4):567-76. DOI: 10.1016/j.yjmcc.2004.02.004. View

13.

Andreozzi F, DAlessandris C, Federici M, Laratta E, Del Guerra S, Del Prato S . Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic.... Endocrinology. 2004; 145(6):2845-57. DOI: 10.1210/en.2003-0939. View

14.

Chan A, Soltys C, Young M, Proud C, Dyck J . Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem. 2004; 279(31):32771-9. DOI: 10.1074/jbc.M403528200. View

15.

Rovetto M, Lamberton W, Neely J . Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ Res. 1975; 37(6):742-51. DOI: 10.1161/01.res.37.6.742. View

16.

Taegtmeyer H, HEMS R, KREBS H . Utilization of energy-providing substrates in the isolated working rat heart. Biochem J. 1980; 186(3):701-11. PMC: 1161705. DOI: 10.1042/bj1860701. View

17.

Taegtmeyer H, Roberts A, Raine A . Energy metabolism in reperfused heart muscle: metabolic correlates to return of function. J Am Coll Cardiol. 1985; 6(4):864-70. DOI: 10.1016/s0735-1097(85)80496-4. View

18.

Doiron B, Cuif M, Chen R, Kahn A . Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J Biol Chem. 1996; 271(10):5321-4. DOI: 10.1074/jbc.271.10.5321. View

19.

Towle H, Kaytor E, Shih H . Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr. 1997; 17:405-33. DOI: 10.1146/annurev.nutr.17.1.405. View

20.

Moule S, Denton R . Multiple signaling pathways involved in the metabolic effects of insulin. Am J Cardiol. 1997; 80(3A):41A-49A. DOI: 10.1016/s0002-9149(97)00457-8. View